Exact Mass: 652.3611

Exact Mass Matches: 652.3611

Found 50 metabolites which its exact mass value is equals to given mass value 652.3611, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Metocurine

NCGC00181151-01

C40H48N2O6+2 (652.3512)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

Metocurine

(1S,16R)-9,10,21,25-tetramethoxy-15,15,30,30-tetramethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁸,²².0²⁷,³¹.0¹⁶,³⁴]hexatriaconta-3,5,8(34),9,11,18(33),19,21,24,26,31,35-dodecaene-15,30-diium

C40H48N2O6 (652.3512)


Metocurine is only found in individuals that have used or taken this drug. It is a non-depolarizing muscle relaxant. Patients on chronic anticonvulsant drugs are relatively resistant to metocurine.(PMID: 9915319)Metocurine antagonizes the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate. This antagonism is inhibited, and neuromuscular block reversed, by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine.

   

n-[2(r)-Hydroxy-1(s)-indanyl]-2(r)-phenylmethyl-4(s)-hydroxy-5-[4-[2-benzofuranylmethyl]-2(s)-[tert-butylaminocarbonyl]-piperazinyl]-pentaneamide

4-[(1-Benzofuran-2-yl)methyl]-1-{4-benzyl-2-hydroxy-4-[(2-hydroxy-2,3-dihydro-1H-inden-1-yl)-C-hydroxycarbonimidoyl]butyl}-N-tert-butylpiperazine-2-carboximidate

C39H48N4O5 (652.3625)


   

Cherimolacyclopeptide D

Cherimolacyclopeptide D

C29H48N8O9 (652.3544)


   

petuniasterone C 7,22-dinicotinate

petuniasterone C 7,22-dinicotinate

C40H48N2O6 (652.3512)


   

Myrtucommulone A

Myrtucommulone A

C38H52O9 (652.3611)


   
   
   

Glu Ile Arg His Val

Glu Ile Arg His Val

C28H48N10O8 (652.3656)


   

Lys Leu Asn His Gln

Lys Leu Asn His Gln

C28H48N10O8 (652.3656)


   

KYVML

Lys-Tyr-Val-Met-Leu

C31H52N6O7S (652.3618)


   

EIRHV

Glu-Ile-Arg-His-Val

C28H48N10O8 (652.3656)


   

PI(22:2(13Z,16Z)/0:0)

1-(13Z,16Z-docosadienoyl)-glycero-3-phospho-(1-myo-inositol)

C31H57O12P (652.3587)


   

LPI 22:2

1-(13Z,16Z-docosadienoyl)-glycero-3-phospho-(1-myo-inositol)

C31H57O12P (652.3587)


   

BA-delta5-3beta,7beta-diol 7betaGlcNAc,24G

3beta-hydroxy-7beta-N-acetylglucosaminylchol-5-en-24-oylglycine

C33H52N2O11 (652.3571)


   

(2S)-4-(1-benzofuran-2-ylmethyl)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butylpiperazine-2-carboxamide

(2S)-4-(1-benzofuran-2-ylmethyl)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butylpiperazine-2-carboxamide

C39H48N4O5 (652.3625)


   

3,6-diamino-N-[[(8Z)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide

3,6-diamino-N-[[(8Z)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide

C25H44N14O7 (652.3517)


   

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (13Z,16Z)-docosa-13,16-dienoate

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (13Z,16Z)-docosa-13,16-dienoate

C31H57O12P (652.3587)


   

Dgdg O-14:1_2:0

Dgdg O-14:1_2:0

C31H56O14 (652.367)


   

Dgdg O-13:1_3:0

Dgdg O-13:1_3:0

C31H56O14 (652.367)


   

1-(13Z,16Z-docosadienoyl)-glycero-3-phospho-(1-myo-inositol)

1-(13Z,16Z-docosadienoyl)-glycero-3-phospho-(1-myo-inositol)

C31H57O12P (652.3587)


   
   

PG O-18:0/7:3;O3

PG O-18:0/7:3;O3

C31H57O12P (652.3587)


   
   

PG P-18:0/7:2;O3

PG P-18:0/7:2;O3

C31H57O12P (652.3587)


   
   
   
   
   
   
   
   
   
   

PI P-18:0/4:1 or PI O-18:1/4:1

PI P-18:0/4:1 or PI O-18:1/4:1

C31H57O12P (652.3587)


   
   

PI P-18:1/4:0 or PI O-18:2/4:0

PI P-18:1/4:0 or PI O-18:2/4:0

C31H57O12P (652.3587)


   
   

PI P-20:1/2:0 or PI O-20:2/2:0

PI P-20:1/2:0 or PI O-20:2/2:0

C31H57O12P (652.3587)


   
   

PI P-22:1 or PI O-22:2

PI P-22:1 or PI O-22:2

C31H57O12P (652.3587)


   

2-[(6s,9s,12s,15s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-isopropyl-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

2-[(6s,9s,12s,15s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-isopropyl-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C29H48N8O9 (652.3544)


   

2-[(6s,9s,12s,15s,18s,23as)-6-[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-isopropyl-12-methyl-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

2-[(6s,9s,12s,15s,18s,23as)-6-[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-isopropyl-12-methyl-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C29H48N8O9 (652.3544)


   

4-[(1r)-1-[(9s,10s,14s)-3,14-dihydroxy-7,7,11,11,13,13-hexamethyl-4-(2-methylpropanoyl)-12-oxo-6,15-dioxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1,3,5(16)-trien-2-yl]-2-methylpropyl]-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione

4-[(1r)-1-[(9s,10s,14s)-3,14-dihydroxy-7,7,11,11,13,13-hexamethyl-4-(2-methylpropanoyl)-12-oxo-6,15-dioxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1,3,5(16)-trien-2-yl]-2-methylpropyl]-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione

C38H52O9 (652.3611)


   

(6s,6ar,10as,14r)-7,10a,13-trihydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6,6a,7,14-tetrahydro-5,11-dioxapentaphene-1,3,9-trione

(6s,6ar,10as,14r)-7,10a,13-trihydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6,6a,7,14-tetrahydro-5,11-dioxapentaphene-1,3,9-trione

C38H52O9 (652.3611)


   

2-[1,4,7,10,13,16-hexahydroxy-18-(1-hydroxyethyl)-15-isopropyl-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

2-[1,4,7,10,13,16-hexahydroxy-18-(1-hydroxyethyl)-15-isopropyl-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C29H48N8O9 (652.3544)


   

4-[(1s)-1-{2,4-dihydroxy-5-[(1r)-1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxocyclohex-1-en-1-yl)-2-methylpropyl]-3-(2-methylpropanoyl)phenyl}-2-methylpropyl]-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione

4-[(1s)-1-{2,4-dihydroxy-5-[(1r)-1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxocyclohex-1-en-1-yl)-2-methylpropyl]-3-(2-methylpropanoyl)phenyl}-2-methylpropyl]-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione

C38H52O9 (652.3611)


   

(2r,3s)-3-[(1r,3as,3bs,4r,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-4-(pyridine-3-carbonyloxy)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2s)-2,3,3-trimethyloxiran-2-yl]butan-2-yl pyridine-3-carboxylate

(2r,3s)-3-[(1r,3as,3bs,4r,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-4-(pyridine-3-carbonyloxy)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2s)-2,3,3-trimethyloxiran-2-yl]butan-2-yl pyridine-3-carboxylate

C40H48N2O6 (652.3512)


   

3-[9a,11a-dimethyl-7-oxo-4-(pyridine-3-carbonyloxy)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(2,3,3-trimethyloxiran-2-yl)butan-2-yl pyridine-3-carboxylate

3-[9a,11a-dimethyl-7-oxo-4-(pyridine-3-carbonyloxy)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(2,3,3-trimethyloxiran-2-yl)butan-2-yl pyridine-3-carboxylate

C40H48N2O6 (652.3512)